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The implantation of the fertilized egg outside the uterine cavity leads to the 
development of ectopic pregnancy. The incidence of ectopic pregnancy is 1/100 births. 
The most common place of ectopic implantation of the fertilized ovum is the oviduct 
(98%) with predilection for the ampullar part of the Fallopian tube. The aim of this study 
was to determine the predictive importance of beta-hCG and progesterone concentration 
compared to ultrasonographic finding in the ectopic pregnancy diagnosis.  
We examined 24 patients with ectopic pregnancies which we divided according to 
the days of amenorrhea into two groups: the first group with the total of 28 patients 
from 16–42 days and another group of 8 patients with amenorrhea longer than 42 days. 
The control group was comprised of 20 patients with vital intrauterine pregnancy, 
gestational age of 42-52 days. Blood samples for quantitative determination of 
hormones were collected on three occasions after 48 hours in the forenoon time in the 
examined and control group of pregnant women. Ultrasonographic examinations of all 
pregnant women were carried out immediately after blood sampling, with the trans-
vaginal approach using "make loop" option, and measurements with an accuracy of 0.1 mm. 
Mean values for beta-hCG range from 698-1774 mlU/ml in the first group of 
pregnant women, and in the second group of 1896 mlU/ml to 4410 mlU/ml with a 
statistically significant difference compared to the values in the control group (p 
<0.001). The concentration of progesterone in the first group of women ranging from 
41-70 nmol/l, and in the second group of 76-94 nmol/l which is also the statistically 
significant difference compared to the control group (p<0.002). We have shown that 
ultrasonographic finding with its parameters reliably predicts the values of biochemical 
parameters both in normal intrauterine pregnancy and in the case of ectopic pregnancy.  
Embryo viability and implantation place condition the values of biochemical 
parameters, which makes establishing the correct diagnose difficult by following only 
these markers. It is necessary to combine the growth dynamics of these hormones with 
ultrasonographic finding as the gold standard in diagnosing ectopic pregnancy. Acta 
Medica Medianae 2011;50(3):16-21. 
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Introduction 
 
Implantation of the fertilized egg outside 
the uterine cavity leads to the development of 
ectopic pregnancy. The incidence of ectopic 
pregnancy is 1/100 births (1). The most common 
site of ectopic implantation of the fertilized ovum 
is the oviduct (98%) with predilection for the 
ampullar part of the Fallopian (Fallopi) tube (2). 
About 17% of women achieve their first pregnancy 
as ectopic, and around 40% of these women will 
not be able to have regular spontaneous pregnancy 
later (3). After surgeries, 50% of women will no 
longer become pregnant, and the risk of repeated 
ectopic pregnancy is 10-15%. After the micro-
surgery with the ectopic pregnancy 1/3 of women 
will never become pregnant, 1/3 of women will 
again have an ectopic pregnancy and 1/3 of 
women will have a regular spontaneous pregnancy 
(4). Human chorionic gonadotropin (hCG) is a 
glycoprotein secreted by syncytiotrophoblast 
cells. In ectopic pregnancy, the concentration of 
beta-hCG is lower in 85% of the cases than the 
level of beta-hCG found in normal pregnancy at a 
similar gestational age (5). In 50% of women 
with ectopic pregnancy, the level of beta-hCG has 
a discontinuous growth alternating with phases of 
decline (6). In the case of ectopic pregnancy, 
corpus luteum secretes a smaller amount of 
progesterone than in normal pregnancies of the 
same gestational age. However, not even the 
known value of progesterone can differentiate 
abnormal pregnancy inside the uterus from an 
ectopic pregnancy  (7). Low level of progesterone 
shows the suspected viability of the pregnancy. 
An important method as a supplement to the 
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quantitative determination of beta-HCG and 
progesterone is a transvaginal ultrasonography, 
which can identify pregnancy in the uterus 
already with the concentration of beta-hCG of 
1500 mIU/ml in 70% of cases, and always when 
the level of beta-hCG exceeds 2500mIU/ml ie. 
about 5 to 6 weeks after the last menstrual 
period (8). 
 
Aim 
 
The aim of this study was to determine the 
predictive significance of biochemical parameters 
in relation to ultrasonographic finding in the 
diagnosis of ectopic pregnancy. 
 
Methods 
 
A prospective, observational study was 
carried out at the Department of Gynecology and 
Obstetrics, Clinical Center Kragujevac in the 
years 2009 and 2010. During the research we 
used a clinical-experimental study model. The 
study was approved by the Ethics Committee of 
Clinical Centre of Kragujevac. In the research 
period, 24 patients were hospitalized with suspected 
ectopic pregnancy. The algorithm of establishing 
the ectopic pregnancy diagnosis in all patients 
consisted of the following procedures, or criteria: 
absence of menstruation, absence of gestational 
sac in the uterine cavity (confirmed by ultrasound 
examination), the increase in levels of beta-hCG, 
and/or histological verification of curettage from 
the uterus. Patients were divided according to the 
days of amenorrhea into two groups: the first 
group with the total of 16 patients from 28–42 
days and another group of 8 patients with 
amenorrhea longer than 42 days. The control 
group was comprised of 20 patients with vital 
intrauterine pregnancy, gestational age of 42-52 
days.  
Blood samples were collected on three 
occasions after 48 hours in the forenoon time in 
groups of patients. Ultrasonographic examinations 
of all pregnant women were carried out immediately 
after blood sampling, with the transvaginal approach 
using "make loop" option, and measurements with 
an accuracy of 0.1 mm. Quantitative measurements 
of beta-hCG level were determined from venous 
blood of patients using the commercial test of the 
company DPC-USA. Tests were based on the 
analytical immunochemiluminescence assay and 
were realized by using the automated analyzer 
IMMULITE 2000 Manufacturer of analyzer is also 
the firm Diagnostics Product Corporation (DPC), 
Los Angeles, California, USA. The assessment of 
progesterone concentration was performed in the 
Laboratory for Nuclear Medicine in the Clinical 
Center of Kragujevac by applying the radioimmuno-
assay method (RIA) that uses marked progeste-
rone with a J-125 (reagent set "INEP" - Zemun, 
Serbia). We performed ultrasonographic examinations 
of pregnant women by transvaginal probe 6.5 
MHz, apparatus GE Volusion 730 3D/4D Ultrasound 
System, Northern Virginia (Washington, USA). 
All the obtained results were deposited into 
the unique data base with required logistic 
control. Statistical analysis included calculation of 
mean values and standard deviations (SD) for 
each numerical parameter and analysis of the 
obtained value in relation to the subgroups (t-
test, Mann-Whitney-u) using the statistical program 
SPSS 17. 
 
Results 
 
Growth dynamics of beta-hCG concentration 
in the examined groups of pregnant women with 
ectopic pregnancy is shown in Tables 1 and 2. 
Statistically significant difference in their distribution 
is demonstrated in relation to the concentration 
of this parameter in the control group of 
pregnant women, Table 3. 
 
Table 1. The display of beta-hCG concentration (mlU/ml) in the examined sample, the first group of pregnant 
women 
 
First group 
28- 42 days of 
amenorrhea 
N Mean 
Standard 
Deviation 
T Df P 
b-hCG 1 16 698.18  61.78 -19.53 15  0.000 
b-hCG 2 16 1160.00 147.87  4.32  15  0.001 
b-hCG 3 16 1774.25 334.32  9.26  15  0.000 
b-hCG1,2,3 – levels of b-hCG collected on three occasions after 48 hours 
 
Table 2. The display of beta-hCG concentration (mlU/ml) in the examined sample, the second group of pregnant 
women 
 
Second group 
>43 days of 
amenorrhea 
N Mean 
Standard 
Deviation 
T Df P 
b-hCG1 8 1896.25  197.11  -11.53  7  0.000 
b-hCG 2 8 2946.25  269.21  4.68  7  0.002 
b-hCG 3 8 4410.87  798.05  6.77  7  0.000 
b-hCG1,2,3 – levels of b-hCG collected on three occasions after 48 hours Evaluation of the importance of biochemical parameters in relation...                                                              Dragan Lončar et al. 
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Table 3. The display of beta-hCG concentration (mlU/ml) in the examined sample, the control group of pregnant 
women 
 
Control group 
42-52 days of 
amenorrhea 
N Mean 
Standard 
Deviation 
T Df P 
b-hCG control 1 20 3472.75 599.40 -22.58  19  0.000 
b-hCG control 2 20 6227.15 527.70  -2.31  19  0.032 
b-hCG control 3 20 1054.,65 782.98  23.08  19  0.000 
b-hCGcontrol 1,2,3 – levels of b-hCG collected on three occasions after 48 hours 
 
Table 4. The display of progesterone concentration (mlU/ml) in the examined sample, the first group of pregnant 
women 
 
First group 
28-42 days of 
amenorrhea 
N Mean 
Standard 
Deviation 
T Df P 
Prg I 16 41.43  1.75  -31.00  15  0.000 
Prg II 16 46.31  1.25  -27.80  15  0.000 
Prg III 16 70.62  1.66  37.46  15  0.000 
Prg I, II, III – levels of progesterone collected on three occasions after 48 hours 
 
Table 5. Display of the progesterone concentration (nmol/l) in the examined sample, the second group of pregnant 
women 
 
Second group 
> 43 days of 
amenorrhea 
N Mean 
Standard 
Deviation 
T Df P 
Prg I 8 76.87 1.64 -13.99  7  0.000 
Prg II 8 91.25 2.37  7.44  7  0.000 
Prg III 8 94.50 4.56  5.88  7  0.001 
Prg I, II, III – levels of progesterone collected on three occasions after 48 hours 
 
Table 6. Display of the progesterone concentration (nmol/l) in the examined sample, the control group of pregnant 
women 
 
Control group 
42-52 days of 
amenorrhea 
N Mean 
Standard 
Deviation 
T Df P 
Prg control 1 20 113.80  2.60  -19.20  19  0.000 
Prg control 2 20 208.20 285.96  1.30  19  0.209 
Prg control 3 20 157.05  2.91  49.24  19  0.000 
Prgcontrol 1,2,3 - progesterone levels collected on three occasions after 48 hours 
 
Table 7. The display of ultrasonographic parameters in the examined groups of pregnant women 
 
Ultrasonographic finding 
First group 
N=16; 28.- 42. days of amenorrhea 
Second group 
N=8; >43. days of amenorrhea 
Control group 
N=20; 42.-52. days of amenorrhea 
GS1 
mm/SD/p 
FH i /ili 
YS1
GM2 
mm/  SD/p 
CRL2 
mm/SD/p 
GMControl 
mm/SD/p 
CRLControl 
mm/SD/p 
3.62±1.02 
p=0.000 
-/- 
24.12±1.12 
p=0.000 
6.65±1.06 
p=0.000 
25.22±.2.12 
p=0.003 
8.09±1.13 
p=0.001 
11.50±1.15 
p=0.209 
-/+ 
30.25±1.38 
p=0.000 
9.00±1.30 
p=0.068 
28.10±2.54 
p=0.002 
10.29±1.63 
p=0.000 
18.12±1.36 
p=0.000 
+/+ 
35.37±1.06 
p=0.000 
12.62±1.06 
p=0.000 
30.05±2.90 
p=0.000 
14.55±2.01 
p=0.004 
*GS-(Gestational Sac); CRL (Crown Rump Length; YS (Yolc Sac); FH (Fetal hearth) 
 
Tables 4 and 5 show the distribution of the 
progesterone level in the examined sample of 
pregnant women in different periods of amenorrhea 
during the ectopic pregnancy. Statistically significant 
difference in secretion of this hormone is demon-
strated in relation to their levels at the intrauterine 
pregnancy, Table 6. 
The importance of information about the 
pregnancy viability and place of implantation of a 
fertilized egg that we followed by transvaginal 
ultrasonography are presented in Table 7. The 
statistically significant difference is shown in 
morphological parameters of early gestation, 
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biochemical parameters (p<0.001) comparing the 
ectopic and intrauterine pregnancy. 
Ultrasonographic parameters of pregnancy 
viability and place of implantation of ovulum 
reliably predict the quantitative values of measured 
hormones in the examined pregnant women. 
 
Discussion 
 
The key to the interpretation of quantitative 
beta-hCG value is not in its number, but in the 
growth dynamics (2, 9). In a normal pregnancy, 
beta-hCG increases so that the average value 
doubles every two days. For this reason, the 
beta-hCG test is usually repeated two days after 
the first test to see if the "beta" properly "doubles". 
As the pregnancy progresses and the value of beta-
hCG grows, the "doubling" time also grows (10). 
Pregnancies that end with miscarriage or ectopic 
pregnancy show lower values as a rule and a slower 
time of growth, although some normal pregnancy 
may also have lower values of hCG (10). Some 
believe that a shorter, "doubling" time represents 
multiple fetuses, which is not true according to some 
researches, although it has been observed that 
women with multiple pregnancy have generally 
higher values of beta-hCG than women with 
singleton pregnancies (11, 12). One should be 
careful and not too fond of calculations with numbers 
in interpreting the results of these tests (13).  
In our study, we presented mean values 
with standard deviations of b-hCG and proge-
sterone and the number of pregnant women 
examined by weeks of pregnancy, specifically from 
4th to 9th weeks. We see that the mean values 
for b-hCG range from 698-1774 mIU/ml in the 
first group of pregnant women with a statistically 
significant difference compared to the values in 
the control group (p<0.001). In the second group 
of pregnant women we found values in the range of 
1896 mIU/ml to 4410 mIU/ml and confirm a 
significant difference in the level of beta-hCG 
(p<0.001) compared to the control group with 
regular intrauterine pregnancy with the gestation 
of 6-9 weeks. The progesterone concentration in 
the first group of women ranges from 41-70 
nmol/L, and in the second group of 76-94 nmol/l 
which is also the statistically significant difference 
compared to the control group (p<0.002) (Tables 
1-6). The progesterone concentration increases 
progressively after ovulation, reaching the plateau in 
the next seven days (luteal phase of menstrual 
cycle) and, if fertilization has occurred, the 
values of the serum progesterone fluctuate within 
the plateau during the 6-7 weeks and then 
progressively increase (14, 15). A medium growth 
can be observed form the 7th week, and from 8th 
week a significantly increased secretion of proge-
sterone. The absence of difference in concen-
trations of progesterone in the 4th and 5th week 
is realistically expected, because at this stage of 
pregnancy place of the progesterone creation is 
corpus luteum (corpus luteum). Significant difference 
between the 5th and 6th weeks that is 6th and 
7th we explain by the ongoing placen-tation, so 
the concentration of progesterone is of dual 
origin - from the corpus luteum and placenta. A 
significant increase in the 8th and 9th weeks, we 
interpret by the increase of secretive capacity of 
the endocrine placenta. Some authors describe a 
temporary decline in progesterone concentration 
between the 5th and 9th weeks, others do not 
record this fall, but they do not also record the 
significant increase in progesterone concentrations 
until the 9th week (12, 16). McCord et al. find 
progressive increase from the 6th to 9th weeks 
(17). In their statements, Mol et al. found that 
during the first four weeks of pregnancy the 
progesterone concentration increases, that over the 
following weeks it does not significantly decrease 
referring to the placental "contribution" in the 
later stages of pregnancy (7). The importance of 
determining progesterone can be reduced by the 
statements of some authors about the existence 
of daily variations of progesterone concentration 
in the same pregnant women (16). Mol et al. discuss 
the fluctuations of progesterone during the day 
without any concrete evidence and conclusions (7).  
Our results, presented in this study, show 
that current fluctuations are not significant. We 
have shown statistically significant difference in 
levels of b-hCG and progesterone levels between 
the examined and control group of pregnant 
women in the given gestational framework. The 
growth dynamics of biochemical parameters in 
our study is consistent with other studies which 
confirms the value of the applied algorithm in the 
ectopic pregnancy diagnosis (17, 18). Ultrasound 
examination after 5-6 weeks gives much better 
foundations for predicting the outcome of pregnancy, 
than only monitoring the value of beta-hCG and 
progesterone (19). We have shown that ultrasono-
graphic finding with its parameters reliably predicts 
the values of biochemical parameters in all the 
examined groups of pregnant women. Viability of 
pregnancy and implantation place condition the 
values of biochemical parameters, which makes 
establishing the correct diagnose difficult by 
following only these markers (19-21). Transvaginal 
ultrasonography, as a gold standard, represents 
an essential link in the modern protocol of the 
diagnostics of ectopic pregnancy (22, 23) (Table 7). 
 
Conclusion 
 
Proper growth of biochemical markers with 
high probability shows the normal course of 
pregnancy. Growth dynamics of beta-hCG and 
progesterone values is a more significant parameter 
of prediction than the specific quantitative values. 
Ectopic pregnancy is a clinical entity that the 
clinician sets a number of dilemmas and concerns. 
Quantitative determination of hormone levels is not 
a reliable diagnostic procedure, especially not in a 
single measurement. It is necessary to combine 
growth dynamics of these hormones with clinical 
examination and ultrasonographic finding, which 
remains a gold standard in ectopic pregnancy 
diagnostics. Numerous scientific reports, as well as 
the results of our research, have shown especially 
high level correlation between the ultrasonographic 
findings and quantitative v a l u e s  o f  b e t a - h C G  a n d  
progesterone in monitoring pregnant women with 
ectopic pregnancy. Evaluation of the importance of biochemical parameters in relation...                                                              Dragan Lončar et al. 
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EVALUACIJA ZNAČAJA BIOHEMIJSKIH PARAMETARA U ODNOSU NA 
ULTRASONOGRAFSKI NALAZ U DIJAGNOSTICI EKTOPIČNE TRUDNOĆE 
 
Dragan Lončar 
 
 
Implantacija oplođene jajne ćelije van materične šupljine dovodi do razvoja 
ektopičnog graviditeta. Incidenca ektopične trudnoće iznosi 1/100 porođaja. Najčešće 
mesto ektopične implantacije oplođenog ovuma je jajovod (98%) sa predilakcijom za 
ampularni deo Falopijeve tube. 
Cilj studije bio je da utvrdi prediktivni značaj koncentracije beta-hCG i progesterona  
u odnosu na  ultrasonogrfaski nalaz u dijagnostici ektopične trudnoće. 
Ispitivali smo 24 bolesnice sa ektopičnom trudnoćom koje smo podelili prema 
danima amenoreje u dve grupe i to: prva grupa od ukupno 16 bolesnica od 28 do 42 
dana i druga grupa od 8 bolesnica sa amenorejom dužom od 42 dana. Kontrolnu grupu 
činilo je 20 trudnica sa vitalnom intrauterusnom trudnoćom gestacijske starosti od 42 do 
52 dana. Uzorci krvi za kvantitativno određivanje hormona su uzimani u tri navrata 
nakon 48 sati u prepodnevnom terminu u ispitivanoj i kontrolnoj grupi trudnica. 
Ultrasonografski pregledi svih trudnica vršeni su neposredno nakon uzimanja uzorka 
krvi, transvaginalnim pristupom sa korišćenjem "make loop" opcije i merenja sa 
preciznošću od 0,1 mm. 
Srednje vrednosti za beta-hCG kreću se u opsegu 698- 1774 mlU/ml u prvoj grupi 
trudnica, a u drugoj grupi od 1896 mlU/ml do 4410 mlU/ml sa statistički značajnom 
razlikom u odnosu na vrednosti u kontrolnoj grupi (p<0,001). Koncentracija progesterona u 
prvoj grupi ispitanica kreće se od 41-70 nmol/l, u drugoj grupi od 76-94 nmol/l, što je 
takođe statistički značajna razlika u odnosu na kontrolnu grupu (p<0,002). Pokazali smo 
da ultrasonografski nalaz sa svojim parametrima pouzdano predviđa vrednosti 
biohemijskih parametara kako u normalnoj intrauterusnoj trudnoći tako i u slučaju 
ektopične trudnoće.  
Vijabilnost ploda i mesto implantacije uslovljavaju vrednosti biohemijskih parametara, 
što veoma otežava postavljanje tačne dijagnoze praćenjem samo ovih markera. 
Potrebno je kombinovati dinamiku rasta ovih hormona sa ultrasonografskim nalazom 
kao zlatnim standardom u dijagnostici ektopičnog graviditeta. Acta Medica Medianae 
2011;50(3):16-21. 
 
Ključne reči: ektopična trudnoća, humani horionski gonadotropin, progesteron, 
ultrasonografija 